Hitesh Thakrar is a Partner of Syncona Investment Management, a leading FTSE 250 company focused on investing in and building global leaders in life sciences. He is an experienced investor in the sector, having spent over 20 years investing in public global equities in the life sciences, technology and the innovation sectors. He has worked at various institutions in equity research and Fund Management from ADIA, the sovereign wealth Fund of Abu Dhabi, JP Morgan, Aviva Group, Dresdner Bank and New Star Asset Management. Hitesh is on the Board of Desktop Genetics, a CRISPR IP library company, backed by Illumina and is an angel investor in early stage Innovation companies. He is also on the Investment Committee of the LBA Scale Up Innovation Fund; a Non-Executive Director of Tropic Biosciences and a Member of the Advisory Board of The Alan Turing Institute. Hitesh holds a degree in Chemistry from King’s College, London, MBA from Cranfield University and CFA, the American Association of Investment Analysts.